QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
LON:SUN

Surgical Innovations Group Share Forecast, Price & News

GBX 2.40
0.00 (0.00 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
2.31
Now: GBX 2.40
2.44
50-Day Range
1.80
MA: GBX 2.16
2.50
52-Week Range
1.03
Now: GBX 2.40
2.60
Volume561,636 shs
Average Volume907,707 shs
Market Capitalization£22.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Surgical Innovations Group plc designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. The OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The Distribution segment distributes medical products through Elemental Healthcare Ltd. The company also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was founded in 1992 and is based in Leeds, the United Kingdom.
Surgical Innovations Group logo

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-113-2307597
Employees100
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£8.22 million
Cash FlowGBX 0.42 per share
Book ValueGBX 1.20 per share

Profitability

Miscellaneous

Market Cap£22.39 million
Next Earnings Date3/29/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 2.40
0.00 (0.00 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SUN News and Ratings via Email

Sign-up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Surgical Innovations Group (LON:SUN) Frequently Asked Questions

What stocks does MarketBeat like better than Surgical Innovations Group?

Wall Street analysts have given Surgical Innovations Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Surgical Innovations Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Surgical Innovations Group's next earnings date?

Surgical Innovations Group is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Surgical Innovations Group
.

How has Surgical Innovations Group's stock been impacted by COVID-19 (Coronavirus)?

Surgical Innovations Group's stock was trading at GBX 1.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SUN shares have increased by 31.5% and is now trading at GBX 2.40.
View which stocks have been most impacted by COVID-19
.

Who are Surgical Innovations Group's key executives?

Surgical Innovations Group's management team includes the following people:
  • Mr. David John Marsh, CEO & Director
  • Mr. Adam Power, Group Devel. Director & Director
  • Ms. Charmaine Day, CFO, Group Financial Controller & Company Sec. (Age 39)
  • Mr. Alex Hogg, Operations Director

Who are some of Surgical Innovations Group's key competitors?

What other stocks do shareholders of Surgical Innovations Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgical Innovations Group investors own include Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), CARBO Ceramics (CRR), Express (EXPR), Hudson Technologies (HDSN), Pentair (PNR), (RRMS) (RRMS), Ritter Pharmaceuticals (RTTR), The Charles Schwab (SCHW) and Terex (TEX).

What is Surgical Innovations Group's stock symbol?

Surgical Innovations Group trades on the London Stock Exchange (LON) under the ticker symbol "SUN."

How do I buy shares of Surgical Innovations Group?

Shares of SUN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Surgical Innovations Group's stock price today?

One share of SUN stock can currently be purchased for approximately GBX 2.40.

How much money does Surgical Innovations Group make?

Surgical Innovations Group has a market capitalization of £22.39 million and generates £8.22 million in revenue each year.

How many employees does Surgical Innovations Group have?

Surgical Innovations Group employs 100 workers across the globe.

What is Surgical Innovations Group's official website?

The official website for Surgical Innovations Group is www.sigroupplc.com.

Where are Surgical Innovations Group's headquarters?

Surgical Innovations Group is headquartered at Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ, United Kingdom.

How can I contact Surgical Innovations Group?

Surgical Innovations Group's mailing address is Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ, United Kingdom. The company can be reached via phone at +44-113-2307597.


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.